CSL Seqirus

About CSL Seqirus

CSL Seqirus is a global leader in the development and production of innovative vaccines, dedicated to protecting public health through advanced immunisation solutions. With a strong commitment to research and development, the company focuses on creating vaccines that address both existing and emerging infectious diseases.

Founded as a part of CSL Limited, CSL Seqirus combines the expertise of two pioneering companies in the vaccine industry. The company operates state-of-the-art manufacturing facilities and employs cutting-edge technology to ensure the highest quality standards in vaccine production.

CSL Seqirus is particularly known for its seasonal influenza vaccines, which are distributed worldwide. The company’s portfolio also includes vaccines for other infectious diseases, contributing significantly to global health initiatives.

With a mission to save lives and improve the health of communities, CSL Seqirus invests heavily in scientific research and collaborates with various health organisations and governments. This collaborative approach enables the company to respond swiftly to public health needs and outbreaks.

In addition to its focus on vaccine development, CSL Seqirus is committed to sustainability and ethical practices. The company strives to minimise its environmental impact while ensuring that its operations are socially responsible.

As a trusted partner in the healthcare sector, CSL Seqirus continues to lead the way in vaccine innovation, aiming to provide effective solutions that protect individuals and communities from infectious diseases.

• Core Activities: Vaccine development, production, and distribution.
• Vision: To be a global leader in immunisation solutions.
• Commitment: Protecting public health through innovation.